Showing results (811-820 of 3,200) with videos related to
Sort By:
Pageof 320
Diagnostic Microbiology and Infectious Disease|December 1, 1995
Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agentsM G Cormican, S A Marshall, R N JonesBiochimica Et Biophysica Acta|April 29, 1998
The specificity and affinity of immunoliposome targeting to oral bacteriaA M Robinson, J E Creeth, M N JonesTopics in Cognitive Science|June 23, 2015
Foraging in Semantic Fields: How We Search Through MemoryThomas T Hills, Peter M Todd, Michael N JonesJournal of Clinical Microbiology|August 1, 1996
Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screenM G Cormican, S A Marshall, R N JonesDiagnostic Microbiology and Infectious Disease|May 1, 1985
BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agentsR N Jones, A L Barry, R R PackerPlacenta|April 13, 2022
Interventions for placental insufficiency and fetal growth restrictionBaylea N Davenport, Rebecca L Wilson, Helen N JonesInternational Journal of Antimicrobial Agents|January 1, 2003
Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000)Ronald N Jones, Douglas J Biedenbach, Ana C GalesDiagnostic Microbiology and Infectious Disease|January 5, 2002
Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA)M A Pfaller, R N Jones, D J Biedenbach, et al.The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 20, 2001
Antimicrobial activity of linezolid against Gram-positive cocci isolated in BrazilH S Sader, A C Gales, R N JonesDiagnostic Microbiology and Infectious Disease|September 12, 2003
Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United StatesKelley A Gordon, Helio S Sader, Ronald N JonesPageof 320